Veterinary Practice Consolidators 2026: The Complete Directory
Veterinary Practice Consolidators 2026: The Complete Directory
Key takeaways
- The U.S. veterinary practice consolidator landscape is dominated by about ten major operators, with Mars Veterinary Health (family-owned by Mars, Incorporated, operating VCA, Banfield, and BluePearl) as the largest and the only major strategic — not PE-backed — exception.
- The biggest 2024-2025 structural event was the merger of Southern Veterinary Partners and Mission Veterinary Partners into Mission Pet Health (840+ locations across 41 states per their own July 2025 announcement).
- The remaining major consolidators — NVA (JAB Holdings), VetCor (Harvest Partners), PetVet Care Centers (Ares Management), Thrive Pet Healthcare (TSG Consumer Partners, formerly Pathway Vet Alliance), AmeriVet (AEA + Oaktree), Veterinary Practice Partners (Pamlico Capital), Heartland Veterinary Partners (Gryphon Investors), Blue River PetCare (Tailwind Capital), Alliance Animal Health (L Catterton), Rarebreed Veterinary Partners (Berkshire Partners), Western Veterinary Partners (Prospect Hill), United Veterinary Care (TA Associates), Community Veterinary Partners (OMERS), and the dozen-plus mid-tier platforms below — are all PE-backed.
- Per-buyer multiples and deal structures are private; what any specific consolidator will actually pay for your specific practice only becomes visible through a structured competitive process with multiple bidders.
- This directory is context for understanding the landscape. Engaging the buyers is work for a sell-side advisor, not the seller alone.
A vet I’d worked with for years called me last fall. Three different veterinary practice consolidator acquisition teams had reached out within 4 weeks.
Different names. Different opening conversations.
Different proposed deal structures. He wanted to know who these companies actually were, who owned them, what kind of practices they were hunting for, and how to think about engaging with the buyer landscape as a whole.
This article is the answer to that conversation. I’ve tried to make it the most clearly sourced and complete directory you’ll find anywhere of who’s actually buying veterinary practices in the U.S. in 2026 — who owns them, how big they are, what kind of practices they target, and what their recent publicly disclosed activity looks like.
A few things you won’t find here. I’m not going to cite specific practice counts for each consolidator.
The publicly available numbers shift constantly with new acquisitions and are not always consistent across sources, so general scale framing (“large network,” “national presence,” “established platform”) is more accurate than a precise figure that may be outdated by the time you read it. I’m also not going to make per-buyer claims about what multiples they pay.
The multiples each consolidator pays for any specific practice are private. The market-level data I can cite from Capstone Partners and Octus tells you the range of multiples actually transacting in the industry, but I won’t tell you “Buyer X pays Y times EBITDA” because no buyer publishes that.
There’s also a more important reason for what’s not in this article. The directory is context, not a buyer-engagement guide. Knowing the names and ownership structures of the major consolidators is useful background. But the actual work of evaluating which of them would pay the most for your specific practice, structuring the conversations so the buyers compete on full deal terms rather than just headline multiples, and managing the diligence and negotiation through closing is not something you should be doing on your own.
Each of these buyers has an experienced acquisition team with a defined playbook. You’re a first-time seller.
The asymmetry is structural, and the way to close it is to have an experienced advisor on your side of the table running the process. I’ll come back to that at the end of the article.
For now, the directory.
The 2026 consolidator landscape, at a glance
The major veterinary practice consolidators operating in the United States in 2026 fall into two ownership categories.
Strategic buyer (one major exception)
Mars Veterinary Health is family-owned by Mars, Incorporated, per Mars company disclosures. Mars operates VCA Animal Hospitals, Banfield Pet Hospital, and BluePearl Specialty and Emergency Pet Hospital.
Across these three brands, Mars Veterinary Health is the largest single owner of veterinary practices in the United States and globally.
Private equity-backed financial buyers (everyone else of significant scale): National Veterinary Associates, Mission Pet Health (the merged Southern Veterinary Partners + Mission Veterinary Partners entity), VetCor, PetVet Care Centers, Thrive Pet Healthcare, AmeriVet Veterinary Partners, Ethos Veterinary Health, MedVet, and Veterinary Practice Partners. The specific PE sponsors backing each platform have changed over time through recapitalizations, and current cap-table details are private.
The investment thesis across all of them is similar — acquire individual practices, integrate operationally into a larger platform, exit at a higher multiple in 3 to 7 years.
Market-wide multiples for veterinary practice acquisitions in 2026 are documented in industry research, but the spread between direct-offer outcomes and competitive-process outcomes on the same practice is the most important variable. Octus’s 2025 sector research notes that direct, single-bidder add-on acquisitions trade meaningfully lower than what competitive processes produce.
Specialty and emergency hospitals generally trade at higher multiples than comparable general practices. The number for any specific practice depends most heavily on whether other buyers are at the table.
For deeper coverage of how multiples are set and what moves them, see our veterinary practice EBITDA multiples guide. For deeper coverage of deal structure mechanics including the increasingly common partnership/JV model, see our PE pricing guide.
The directory:
1. Mars Veterinary Health (VCA, Banfield, BluePearl)
| Quick facts | Detail |
|---|---|
| Ownership | Family-owned by Mars, Incorporated |
| Backing type | Strategic (not PE-backed) |
| Brands | VCA Animal Hospitals, Banfield Pet Hospital, BluePearl Specialty and Emergency |
| Geography | National U.S. + Canada + Japan |
| 2025 reported activity | ~180 U.S. clinics acquired (per Mordor Intelligence) |
| Target profile | Multi-doctor GP (VCA) · PetSmart-located preventive (Banfield) · Specialty/ER (BluePearl) |
| Hold horizon | Long-term holder (family-owned, no fund exit timeline) |
| Brand preservation | Historically rebrands acquired practices more aggressively than PE-backed peers |
Ownership
Family-owned by Mars, Incorporated. The strategic exception in the consolidator market — not private equity-backed.
Brands and scale (per Mars company disclosures)
- VCA Animal Hospitals operates a large national network of small animal veterinary hospitals across the U.S., Canada, and Japan.
- Banfield Pet Hospital operates a large national network across the United States and Puerto Rico, with the majority co-located inside PetSmart stores.
- BluePearl Specialty and Emergency Pet Hospital operates a network of specialty and emergency hospitals across multiple U.S. states.
Combined footprint
Mars Veterinary Health is the largest single veterinary practice owner globally per Mars company disclosures.
Recent named activity
Mars continues steady acquisition activity, though Mars does not publish quantified U.S.-only annual deal totals.
Target profile (per public disclosures)
Established practices that fit the profile of one of the three brands — multi-doctor general practice (VCA), PetSmart-co-located preventive care (Banfield), or specialty/emergency hospitals (BluePearl).
What to know about Mars as a buyer
Mars is a long-term holder by structure (a privately-held family business, not a fund with a defined exit timeline). The integration approach for each of the three brands is governed by each brand’s operating playbook.
2. National Veterinary Associates (NVA)
| Quick facts | Detail |
|---|---|
| Ownership | JAB Holdings (Luxembourg-based investment vehicle of the Reimann family) |
| Backing type | PE-style long-hold (JAB acquired NVA from Ares Management in 2019 for ~$5.3 billion) |
| Scale | Major global veterinary network across U.S., Canada, UK, Australia, New Zealand |
| Notable 2021 activity | Compassion First Pet Hospitals merged into NVA |
| Target profile | Multi-doctor general practice + specialty hospitals |
| Hold horizon | Longer than typical 3-5 year PE cycle (JAB long-term posture) |
| Brand preservation | Generally preserves local practice branding post-acquisition |
| Other JAB portfolio | Krispy Kreme, Panera Bread, Pret a Manger, Caribou Coffee, Peet’s Coffee, Keurig Dr Pepper |
Ownership
Owned by JAB Holdings, per JAB and NVA company disclosures. JAB Holdings is the privately-held Luxembourg-based investment vehicle of Germany’s Reimann family.
JAB acquired NVA in 2019 from Ares Management for approximately $5.3 billion. Beyond NVA, JAB’s portfolio includes Krispy Kreme, Panera Bread, Pret a Manger, Caribou Coffee, Peet’s Coffee, and Keurig Dr Pepper.
Scale (per company disclosures)
NVA operates a major global veterinary network with operations across the United States, Canada, United Kingdom, Australia, and New Zealand.
Recent named activity
In 2021, JAB merged Compassion First Pet Hospitals into NVA, significantly expanding NVA’s specialty hospital footprint per public announcements at the time.
Target profile (per public disclosures)
General practice plus specialty and emergency hospitals. NVA’s specialty footprint expanded substantially when JAB-owned NVA acquired Ethos Veterinary Health in 2022-2023, integrating Ethos’s referral specialty and emergency network into NVA.
NVA’s company materials describe a focus on multi-doctor practices across companion animal, equine, and pet resort operations.
What to know about NVA as a buyer
JAB’s parent fund structure operates with a longer hold horizon than the typical 3-to-5 year private equity cycle, per JAB’s public investment posture.
3. Mission Pet Health (formed from Southern Veterinary Partners + Mission Veterinary Partners)
| Quick facts | Detail |
|---|---|
| Ownership | Privately-held, PE-backed |
| Backing type | PE-backed combined platform |
| Formation | Merger of Southern Veterinary Partners (SVP) + Mission Veterinary Partners (MVP) finalized late 2024 |
| Brand launch | July 2025 (per Mission Pet Health press release July 21, 2025) |
| Scale | 840+ locations across 41 states, 20,000+ employees |
| Leadership | Dr. Jay Price, SVP founder, serves as CEO of Mission Pet Health |
| Target profile | General practice — concentrated in Southeast, Sun Belt, and Midwest |
| Notable | One of the largest U.S. veterinary practice operators post-merger |
Ownership
Privately-held, PE-backed. Mission Pet Health is the post-merger entity created when Southern Veterinary Partners (SVP) and Mission Veterinary Partners (MVP) completed a formal merger in late 2024.
The combined brand was publicly launched in mid-2025.
Scale (per Mission Pet Health‘s own July 2025 announcement and Bham Now coverage in August 2025): Mission Pet Health operates 840+ veterinary locations across 41 states, with more than 20,000 employees. The combined entity is one of the largest veterinary practice operators in the United States.
Corporate history
SVP was founded in 2014 by Dr. Jay Price in Birmingham, Alabama, and grew into a major U.S. veterinary consolidator with substantial presence in the Southeast and Sun Belt.
MVP was founded in 2017 by veterinary executives including Dr. Jeff Rothstein and operated as a veterinary consolidator partner across multiple states.
The two organizations entered into a formal merger in late 2024 (per the Mission Pet Health press release dated July 21, 2025) and unveiled the combined Mission Pet Health brand publicly in July and August 2025.
Leadership
Dr. Jay Price, the founder and CEO of SVP, serves as CEO of Mission Pet Health.
Recent named activity
Beyond the SVP/MVP merger itself, Mission Pet Health continues active acquisition through the combined platform’s regional teams.
Target profile (per public disclosures)
General practice, with concentration in the Southeast, Sun Belt, and Midwest reflecting the combined footprints of the legacy SVP and MVP networks.
4. VetCor
| Quick facts | Detail |
|---|---|
| Ownership | Harvest Partners (PE) per Harvest Partners portfolio disclosures |
| Backing type | PE platform |
| Founded | Late 1990s — one of the oldest PE-backed veterinary consolidators |
| Scale | 860+ veterinary practices in U.S. and Canada per VetCor corporate site |
| Geography | Concentrated East Coast and Midwest per company location disclosures |
| Target profile | General practice |
Ownership
Backed by Harvest Partners (PE) per Harvest Partners portfolio disclosures.
Scale
VetCor operates 860+ veterinary practices across the U.S. and Canada per its corporate site, with concentration on the East Coast and in the Midwest.
Target profile (per public disclosures)
General practice.
Corporate history
One of the older PE-backed veterinary consolidators in the U.S., dating to the late 1990s.
5. PetVet Care Centers
| Quick facts | Detail |
|---|---|
| Ownership | Ares Management (PE) per Ares portfolio disclosures |
| Backing type | PE platform |
| Scale | 450+ general practice, specialty, and emergency hospitals per PetVet corporate site |
| Hospital mix | General + specialty + emergency hospitals |
| Target profile | General practice with some specialty and emergency hospitals |
Ownership
Backed by Ares Management (PE), which lists PetVet Care Centers as a portfolio company.
Scale (per company disclosures)
PetVet Care Centers operates a network of 450+ general practice, specialty, and emergency veterinary hospitals across the United States per its corporate site.
Target profile (per public disclosures)
General practice with some specialty and emergency hospitals.
6. Thrive Pet Healthcare (formerly Pathway Vet Alliance)
| Quick facts | Detail |
|---|---|
| Ownership | TSG Consumer Partners (PE) — acquired in 2020 |
| Backing type | PE platform |
| Prior name | Pathway Vet Alliance — same platform, rebranded as Thrive |
| Scale | 400+ primary, specialty, and acute care hospitals per Thrive corporate site |
| Hospital mix | General, specialty, and emergency hospitals |
| Target profile | General practice plus specialty and emergency |
Ownership
Backed by TSG Consumer Partners, which acquired Thrive Pet Healthcare (then Pathway Vet Alliance) in 2020.
Scale (per company disclosures)
Thrive Pet Healthcare operates 400+ primary, specialty, and acute care hospitals per its corporate site. Octus’s 2025 research describes the platform as “operating a nationwide network of over 400 general, specialty and emergency veterinary hospitals.”
Naming note
The company rebranded from Pathway Vet Alliance to Thrive Pet Healthcare. Both names refer to the same platform.
Target profile (per public disclosures)
General practice plus some specialty and emergency hospitals.
7. AmeriVet Veterinary Partners
| Quick facts | Detail |
|---|---|
| Ownership | AEA Investors + Oaktree Capital Management (PE) per AmeriVet “About” |
| Backing type | PE platform |
| Scale | 230+ veterinary practices in 35 states and 1 Canadian province per AmeriVet corporate site |
| Target profile | Companion-animal GP (some mixed-animal and equine) |
Ownership
Backed by AEA Investors and Oaktree Capital Management per AmeriVet’s corporate “About” page.
Recent activity
AmeriVet operates as one of the more active mid-market acquirers in the U.S. veterinary M&A market. Specific deal counts are not publicly enumerated by the company on an annual basis.
Target profile (per public disclosures)
General practice.
8. Ethos Veterinary Health (now part of NVA)
| Quick facts | Detail |
|---|---|
| Ownership | Owned by NVA (JAB Holdings) — acquired by NVA in 2022-2023 |
| Backing type | Part of NVA’s specialty/emergency footprint |
| Hospital mix | Specialty referral and 24-hour emergency hospitals |
| Target profile | Specialty and emergency hospitals (under NVA umbrella) |
Ethos Veterinary Health was acquired by NVA in 2022-2023 and is no longer an independent consolidator. Ethos’s specialty referral and emergency network is now integrated into NVA’s broader specialty and emergency footprint per NVA company materials.
Sellers receiving an offer that references Ethos are effectively engaging with NVA’s deal team.
9. MedVet
Ownership
Private equity-backed.
Target profile (per public disclosures)
Specialty and emergency hospitals. MedVet’s portfolio focuses on multi-specialty hospitals with full emergency capabilities.
10. Veterinary Practice Partners (VPP)
| Quick facts | Detail |
|---|---|
| Ownership | Pamlico Capital (PE) per Pamlico portfolio disclosures |
| Backing type | PE platform with veterinarian co-ownership model |
| Scale | 140+ veterinary hospitals across 31 states per VPP corporate site |
| Target profile | Mid-market companion-animal GP — co-ownership model with veterinarians |
Ownership
Backed by Pamlico Capital (PE). VPP generally acquires majority but retains a significant doctor stake under a co-ownership model.
Target profile (per public disclosures)
Mid-market general practice with veterinarian co-ownership.
Has a consolidator reached out to you? Get a Free Practice Value Estimate — we’ll evaluate the buyer pool that fits your specific practice profile and tell you what your practice would likely clear in a structured competitive process. No upfront cost, no obligation.
Mid-tier consolidators (also active acquirers in 2026)
These platforms participate in competitive processes for specific geographic or specialty profiles. The fragmentation in this tier means that for any specific practice, the buyer most willing to pay aggressively often is not one of the top 10.
Smaller PE-backed groups with strategic gaps in their portfolios sometimes pay above the top-tier consolidators for practices that fill specific geographic or specialty holes.
11. Heartland Veterinary Partners
| Quick facts | Detail |
|---|---|
| Ownership | Gryphon Investors (PE, majority since 2020) |
| Scale | 200+ animal hospitals per Heartland corporate site |
| Target profile | Primarily small-animal general practice |
12. Blue River PetCare
| Quick facts | Detail |
|---|---|
| Ownership | Tailwind Capital (PE) per Tailwind portfolio disclosures |
| Scale | 180+ veterinary practices across 29 states per Blue River corporate site |
| Target profile | General practice companion-animal hospitals, long-term ownership focus |
13. Alliance Animal Health
| Quick facts | Detail |
|---|---|
| Ownership | L Catterton (PE) per L Catterton portfolio disclosures |
| Scale | 300+ veterinary hospitals across 40 states and Canada per Alliance corporate site |
| Target profile | Companion-animal GP, some mixed-animal and equine practices |
14. Rarebreed Veterinary Partners
| Quick facts | Detail |
|---|---|
| Ownership | Berkshire Partners (PE) per Berkshire portfolio disclosures |
| Scale | 130+ GP, specialty, and emergency hospitals per Rarebreed corporate site |
| Target profile | Mixed GP + specialty + emergency, with focus on Northeast |
| Notable | Markets explicit co-ownership / partnership equity model |
15. Western Veterinary Partners
| Quick facts | Detail |
|---|---|
| Ownership | Prospect Hill Growth Partners (PE) |
| Scale | 130+ veterinary practices across the Western and Central U.S. per company site |
| Target profile | Primarily small-animal GP and some mixed-animal practices in targeted regions |
16. United Veterinary Care (UVC)
| Quick facts | Detail |
|---|---|
| Ownership | TA Associates (PE) per TA Associates portfolio disclosures |
| Scale | 125+ veterinary hospitals in the U.S. and Canada per UVC corporate site |
| Target profile | Mix of GP and specialty/emergency hospitals |
17. Community Veterinary Partners (CVP)
| Quick facts | Detail |
|---|---|
| Ownership | OMERS (Ontario Municipal Employees Retirement System) per VetIntegrations |
| Scale | 125+ hospitals per CVP corporate site |
| Target profile | Companion-animal GP, partnership-oriented model |
18. Innovetive PetCare
| Quick facts | Detail |
|---|---|
| Ownership | Metalmark Capital (PE) per Metalmark portfolio disclosures |
| Scale | 110+ veterinary hospitals across 17 states per Innovetive corporate site |
| Target profile | Small-animal GP, specialty, and emergency hospitals |
19. Lakefield Veterinary Group
| Quick facts | Detail |
|---|---|
| Ownership | Family-owned (Rauenhorst family office) — not PE-backed |
| Scale | 100+ veterinary practices in the U.S. and Canada per Lakefield corporate site |
| Target profile | Small-animal GP with some mixed-animal and specialty, long-term ownership horizon |
20. Encore Vet Group
| Quick facts | Detail |
|---|---|
| Ownership | North Castle Partners (PE) per North Castle portfolio disclosures |
| Scale | 75+ partner hospitals per Encore corporate site |
| Target profile | Primarily small-animal GP, partner-to-community-practices framing |
21. Companion Pet Partners
| Quick facts | Detail |
|---|---|
| Ownership | Cortec Group (PE) per Cortec portfolio disclosures |
| Scale | 70+ veterinary hospitals across the Western U.S. per Companion corporate site |
| Target profile | Small-animal GP with some specialty/ER |
22. CareVet
| Quick facts | Detail |
|---|---|
| Ownership | Founder-led with investor backing (specific PE sponsor not publicly disclosed) |
| Scale | 130+ veterinary hospitals across the U.S. per CareVet corporate site |
| Target profile | Small-animal GP, emphasis on family-owned practice acquisitions |
23. Veterinary Innovative Partners (VIP)
| Quick facts | Detail |
|---|---|
| Ownership | Innovatus Capital Partners (PE) per Innovatus portfolio disclosures |
| Scale | 40+ practices across the East Coast and Midwest per VIP corporate site |
| Target profile | Primarily small-animal GP and some emergency/urgent care |
24. Veritas Veterinary Partners
| Quick facts | Detail |
|---|---|
| Ownership | Chicago Pacific Founders (PE) per CPF portfolio disclosures |
| Scale | Specialty and emergency hospital group (newer platform, formed ~2022) |
| Target profile | Specialty and emergency hospitals only |
25. Veterinary Emergency Group (VEG)
| Quick facts | Detail |
|---|---|
| Ownership | PE-backed (specific sponsor varies by source) |
| Scale | 36+ emergency locations per VetIntegrations 2025 |
| Target profile | Emergency-only veterinary practices |
TE-tracked consolidators with verified market activity
The platforms below appear consistently in TE’s territory-level market intelligence as active consolidators that have acquired or operate U.S. veterinary practices in 2024-2026. For names where ownership is publicly disclosed by the consolidator or its PE sponsor, that is noted.
For names without publicly disclosed ownership details, only the name appears — we will not speculate.
General practice consolidators
- American Veterinary Group — PE-backed consolidator (multi-state GP footprint per company materials).
- Bond Vet — VC-backed veterinary primary care chain, Warburg Pincus-backed per Bond Vet press releases.
- Modern Animal — VC-backed veterinary primary care chain per Modern Animal corporate site.
- Petfolk — PE-backed primary care veterinary chain per Petfolk corporate site.
- GoodVets — PE-backed primary care platform per GoodVets corporate materials.
- PetVet365 — Mars Veterinary Health–affiliated franchise model per Mars/Banfield disclosures.
- Suveto — PE-backed consolidator per Suveto corporate site.
- Lovet — multi-site GP platform per Lovet corporate site.
- EverVet Partners — regional PE-backed consolidator per EverVet corporate site.
- VetnCare — PE-backed multi-site platform.
- VetEvolve — multi-site veterinary platform.
- WellHaven Pet Health — PE-backed multi-site veterinary platform per WellHaven corporate site.
- Small Door — VC-backed veterinary membership / primary care chain per Small Door corporate site.
- Heart + Paw — PE-backed multi-site veterinary platform per Heart + Paw corporate site.
- Hometown Veterinary Partners — multi-site veterinary platform.
- Destination Pet — multi-site pet care and veterinary platform per Destination Pet corporate site.
Specialty / dermatology / emergency focused
- Animal Dermatology Clinic — specialty veterinary dermatology network per Animal Dermatology Clinic corporate site.
For each of these, the specific deal terms, practice count, and per-buyer pricing are not publicly disclosed and become visible only through a structured competitive process where the buyer competes against peers. Owners receiving outreach from any of these platforms should evaluate the offer in a competitive context rather than against the initial number alone.
Smaller and regional consolidators
Beyond the named consolidators above, additional smaller and regional platforms participate in mid-market U.S. veterinary M&A in 2026, including CityVet, Valley Veterinary Care, Vets Pets, Pet Paradise, Inspire Veterinary Partners, and Galaxy Vets, among others. Their scale and target profiles vary substantially.
For any specific practice, the right competitive process may include one or more of these as targeted bidders alongside the major and mid-tier platforms listed above.
How the consolidator landscape has changed in 2025-2026
Several structural shifts since the 2021-2022 cycle peak are documented in industry research.
Major consolidation among consolidators
The Mission Pet Health merger (formally closed late 2024, brand launched July 2025) is the most significant single structural event in the 2024-2025 U.S. vet practice consolidation market. The combination of Southern Veterinary Partners and Mission Veterinary Partners into Mission Pet Health created one of the largest U.S. veterinary practice operators with 840+ locations across 41 states, materially changing the competitive dynamics for sellers in the markets where both legacy platforms previously operated.
Acquisition pace moderated then refocused
Capstone Partners and Octus both describe the 2022-2024 window as a period of compressed multiples and more selective acquisitions, with PE-backed buyers concentrating on larger, multi-doctor practices over smaller, owner-dependent ones. By 2026, Capstone reports pet sector M&A volume has roughly doubled in the first months of the year versus the same window of 2025.
Deal structures evolved
Industry legal commentary from Dechert LLP and Holland & Knight in 2025-2026 describes how deal structures in healthcare and veterinary practice acquisitions have adjusted to changed financing conditions and regulatory dynamics.
One specific structural shift worth noting: an increasing number of PE-backed veterinary consolidators are offering partnership or joint venture structures rather than 100 percent acquisitions. Per MB Law Firm’s 2025 commentary on healthcare M&A trends, buyers in these structures acquire a majority stake in the practice (typically 60 to 80 percent), leaving the seller with 20 to 40 percent retained equity in the practice itself, with a contractual put/call mechanism that defines the buyout date and formula price for the retained equity.
Rarebreed Veterinary Partners markets co-ownership explicitly in its company materials. Mission Pet Health continues the “Ownership Opportunities” framework that SVP had established before the merger, offering structured joint venture options for larger groups.
IVC Evidensia (parent of VetStrategy in Canada) describes joint-ownership structures in many of its clinics. Encore Vet Group markets partnership over pure acquisition.
The shift toward partnership models is meaningful for sellers because the structure provides defined liquidity at a known formula price rather than relying on the platform’s eventual exit, and it provides ongoing distributions during the hold period. For deeper coverage of deal mechanics including the partnership model, see our article on how much private equity is paying for veterinary practices.
Regulatory scrutiny increased
Several states have introduced legislation tightening corporate-practice-of-medicine rules and limiting certain management services organization structures used in healthcare and veterinary consolidation. New York’s Assembly Bill 9042 and North Carolina’s Senate Bill 570 are notable 2025-2026 examples, per the Dechert and Holland & Knight legal commentary.
These laws affect how deals are structured rather than directly capping purchase prices.
A real example from our work
A 3-doctor practice in a rural Midwestern market expected to clear $4-5 million when they engaged us. Through the competitive process, the final closed deal landed at $12.5 million — roughly 2.5 times the owner’s expectation.
The expectation gap reflects what owners typically anticipate from direct offers versus what a structured process actually produces.
What this directory is, and what it isn’t
The information above is context. Knowing which consolidators exist, who owns them, what kinds of practices they target, and how the market is shifting is useful background.
But the actual work of selling your practice into this landscape — figuring out which specific buyers would be the strongest fit for your specific practice, structuring the conversations so multiple qualified buyers compete on full deal terms rather than just headline multiples, normalizing your EBITDA properly so the financial review during diligence proceeds smoothly, negotiating the deal structure components against each other to maximize cash at close while preserving partnership upside, and managing the closing through definitive purchase agreement and regulatory transfers — that’s not work most first-time sellers should be doing on their own.
Each major consolidator has an experienced acquisition team with substantial transaction volume across the industry. They understand the standard sequence of negotiations, the typical concession patterns, and the rhythm of diligence.
You may have built a tremendous practice over 25 years, but most owners have not negotiated a large M&A transaction before. The information asymmetry is one of the reasons sell-side advisors exist.
The way to close that asymmetry is to have a sell-side advisor running the process on your behalf, with the institutional knowledge of how each buyer operates and the leverage of multiple bidders competing for your practice in parallel. The methodology we use is what we call the Elite Selling System — we hand-select and vet every consolidator who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive bidding window inside that vetted group.
The economic difference between a direct sale to a single consolidator and the Elite Selling System — across the deals I’ve watched over the past four-plus years — consistently runs 3 to 7 additional multiples of EBITDA of EBITDA on the headline number, plus material improvements in cash at close, earnout terms, rollover or partnership equity, and non-compete provisions.
“I had previously looked at selling the practice on my own, and I had talked to five different companies about this and had gone through the process individually, and none of it turned out to my satisfaction. After I signed up with Tom, he marketed me to these interested companies. There was competition amongst those interested. It was so relieving at the end of it to know that I got the very best deal possible!”
— David Graeff, Cedar Rapids, Iowa
The right next step
If you’re inside the 2-year window before selling — or if a consolidator has already reached out — there is exactly one productive thing to do first, and it doesn’t involve talking to any of these buyers.
Get an honest, defensible read on what your specific practice would actually clear in a structured competitive process. Not what the buyer who called teased on the first conversation.
The real number, with the math behind it, with the right buyer pool identified for your specific practice profile and geography.
That read is what we built our work to provide.
Get a Free Practice Value Estimate →
Send us your practice profile — revenue, EBITDA, doctor count, geography, specialty mix. We pull your normalized EBITDA properly.
We identify the right group of consolidator and non-consolidator buyers for your specific situation. We give you a defensible value range with the assumptions behind it.
The estimate is free and there’s no obligation to engage further.
If you decide to move forward with TE running your sale process, the engagement is success-based — no upfront fees, no retainer. We get paid only when a deal closes, and only out of the value our process delivers above what you would have realized through a direct conversation with any one buyer.
Further reading
These are the related TE resources I’d point any vet considering a sale toward. The consolidator directory tells you who’s buying.
These articles tell you what they pay, how they structure offers, what to negotiate, and how the sale process actually works.
- Veterinary practice EBITDA multiples in 2026 — what each consolidator (and the broader market) actually pays for practices, by size and profile, in 2026.
- How much private equity is paying for veterinary practices — the PE business model and the four components of any PE-backed offer.
- How to sell a veterinary practice — the 7-step sale process, end to end, including tax considerations and what life looks like after closing.
- Selling your veterinary practice to NVA — the buyer-specific deep dive on NVA and JAB Holdings.
- Our practice sale results — case studies and outcomes from the practices we’ve represented.
- Testimonials from selling veterinarians — what former clients have said about working through the Elite Selling System.
- About Transitions Elite — the team, the methodology, the firm’s track record.
- Transitions Elite services — what TE actually delivers across the engagement.
- Contact Transitions Elite — direct line to begin the conversation.
Frequently asked questions
Who are the largest veterinary practice consolidators in the United States?
The largest veterinary practice consolidators operating in the U.S. in 2026 include Mars Veterinary Health (operator of VCA, Banfield, and BluePearl per Mars Inc. company disclosures), National Veterinary Associates (a major global veterinary network owned by JAB Holdings), Mission Pet Health (formed in late 2024 through the merger of Southern Veterinary Partners and Mission Veterinary Partners, with combined operations across 41 states per the 2025 merger announcement), VetCor, PetVet Care Centers, Thrive Pet Healthcare (formerly Pathway Vet Alliance), AmeriVet Veterinary Partners, Ethos Veterinary Health, MedVet, and Veterinary Practice Partners.
Which veterinary consolidators are private equity-backed and which are strategic buyers?
Most major veterinary consolidators in 2026 are private equity-backed. National Veterinary Associates (owned by JAB Holdings per JAB and NVA disclosures), Mission Pet Health, VetCor, PetVet Care Centers, Thrive Pet Healthcare, AmeriVet, Ethos Veterinary Health, MedVet, and Veterinary Practice Partners are PE-backed (specific sponsors vary by platform and have changed over time through recapitalizations).
Mars Veterinary Health (operating VCA, Banfield, and BluePearl) is the major strategic exception — it is family-owned by Mars, Incorporated, per Mars company disclosures.
What is Mission Pet Health and how is it different from SVP and MVP?
Mission Pet Health is the post-merger brand of the combined entity formed when Southern Veterinary Partners (SVP) and Mission Veterinary Partners (MVP) entered into a formal merger in late 2024. Per the Mission Pet Health press release dated July 21, 2025, the public brand launch was completed in mid-2025.
The combined company operates 840+ veterinary locations across 41 states with more than 20,000 employees. Dr.
Jay Price, who founded SVP in 2014, serves as CEO of Mission Pet Health. SVP and MVP are now legacy components of the single combined company under the Mission Pet Health brand.
What multiples do veterinary consolidators pay in 2026?
Per-buyer pricing is not publicly disclosed in veterinary practice acquisitions. Industry-wide data is the most reliable reference.
Octus’s 2025 private credit research notes that direct, single-bidder add-on acquisitions trade meaningfully lower than the multiples competitive processes produce on the same practice. Specialty and emergency hospitals generally trade at higher multiples than comparable general practices.
The headline number for any specific practice depends most heavily on whether other buyers are at the table.
Is veterinary M&A activity increasing in 2026?
Yes. Capstone Partners‘ April 2026 Pet Sector M&A Update reported 18 pet sector M&A deals in the first months of 2026, more than double the 8 deals tracked in the same period of 2025.
Vet & Health accounted for half of the 2026 activity. The 2024 merger that created Mission Pet Health from the SVP/MVP combination — formalized in late 2024 and publicly branded in July 2025 — is one of several major structural events shaping the 2026 market.
What revenue size attracts consolidator interest?
Most major PE-backed consolidators publicly describe their target acquisition profile as multi-doctor practices with at least $2 million in revenue. Capstone Partners’ market commentary and Octus’s sector research both note that institutional acquirers have generally focused on larger, multi-doctor practices over the past several years.
Sources
Industry M&A research and market data
- Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com
- Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion — VSOs Under Increasing Pressure.” 2025. octus.com
- Mordor Intelligence. “Veterinary Medicine Market.” mordorintelligence.com
- Today’s Veterinary Business — industry coverage of veterinary consolidation, 2024-2025.
Buyer company disclosures and merger announcements
- Mars, Incorporated — company disclosures and brand materials for Mars Veterinary Health, VCA Animal Hospitals, Banfield Pet Hospital, and BluePearl.
- Mission Pet Health. “Southern Veterinary Partners and Mission Veterinary Partners Join Together as Mission Pet Health.” July 21, 2025. missionpethealth.com
- Bham Now. “Birmingham’s Southern Veterinary Partners merges to form new national giant.” August 4, 2025.
- National Veterinary Associates — corporate “About” page and materials.
- JAB Holdings — public disclosures on the 2019 acquisition of NVA.
- Compassion First Pet Hospitals — 2021 NVA merger announcement.
Legal, regulatory, and deal structure analysis
- MB Law Firm. “Joint Ventures, Longer Commitments, and the Rise of Earn-Outs.” 2025. mblawfirm.com
- Dechert LLP. “Healthcare Investments Flash Alert — Latest Developments.” 2025. dechert.com
- Holland & Knight. “Q1 Recap on Proposed Legislation Affecting Healthcare Consolidation.” 2026. hklaw.com
Melani Seymour, co-founder of Transitions Elite, helps veterinary practice owners take action now to maximize value and secure their future.
With over 15 years of experience guiding thousands of owners, she knows exactly what it takes to achieve the best outcome.
Ready to see what your practice is worth?
